Show simple item record

dc.contributor.authorRadfar, Seyed Ramin
dc.contributor.authorDe Jong, Cornelis
dc.contributor.authorFarhoudian, Ali
dc.contributor.authorEbrahimi, Mohsen
dc.contributor.authorRafei, Parnian
dc.contributor.authorVahidi, Mehrnoosh
dc.contributor.authorYunesian, Masud
dc.contributor.authorKouimtsidis, Christos
dc.contributor.authorArunogiri, Shalini
dc.contributor.authorMassah, Omid
dc.contributor.authorDeylamizadeh, Abbas
dc.contributor.authorBrady, Kathleen
dc.contributor.authorBusse, Anja
dc.identifier.citationRadfar, S.R. and De Jong, C. and Farhoudian, A. and Ebrahimi, M. and Rafei, P. and Vahidi, M. and Yunesian, M. et al. 2020. Reorganization of Substance Use Treatment and Harm Reduction Services during the COVID-19 Pandemic: A Global Survey. Frontiers in Psychiatry. 12: 639393.

Background: The COVID-19 pandemic has impacted people with substance use disorders (SUDs) worldwide and healthcare systems have reorganized their services in response to the pandemic. Methods: One week after the announcement of the COVID-19 as a pandemic, in a global survey, 177 addiction medicine professionals described COVID-19-related health responses in their own 77 countries in terms of SUD treatment and harm reduction services. The health response is categorized around (1) managerial measures and systems, (2) logistics, (3) service providers and (4) vulnerable groups. Results: Respondents from over 88% of countries reported that core medical and psychiatric care for SUDs had continued; however, only 56% of countries reported having had any business continuity plan, and, 37.5% of countries reported shortages of methadone or buprenorphine supplies. Participants of 41% of countries reported partial discontinuation of harm-reduction services such as needle and syringe programs and condom distribution. 57% of overdose prevention interventions and 81% of outreach services also having been negatively impacted. Conclusions: Participants reported that SUD treatment and harm reduction services had been significantly impacted globally early during the COVID-19 pandemic. Based on our findings, we provide a series of recommendations to support countries to be prepared more efficiently for future waves or similar pandemics to 1) help policymakers generate business continuity plans, 2) maintain use of evidence-based interventions for people with SUDs, 3) be prepared for adequate medication supplies, 4) integrate harm reduction programs with other treatment modalities and 5) have specific considerations for vulnerable groups such as immigrants and refugees. Highlights: COVID-19 negatively impacted services for PWSUD globally. Addiction medicine downgraded more than other psychiatry services. Business continuity plan for PWSUD services reported only in about half of the countries. Refugees & migrants had more negative impact compared to other vulnerable groups. Harm reduction services discontinued partially or totally during pandemic.

dc.titleReorganization of Substance Use Treatment and Harm Reduction Services during the COVID-19 Pandemic: A Global Survey
dc.typeJournal Article
dcterms.source.titleFrontiers in Psychiatry
curtin.accessStatusOpen access
curtin.contributor.scopusauthoridMyers-Franchi, Bronwyn [7202684194]

Files in this item


This item appears in the following Collection(s)

Show simple item record
Except where otherwise noted, this item's license is described as